Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
34,494,303
-
Share change
-
-1,568,654
-
Total reported value
-
$55,877,865
-
Put/Call ratio
-
1.6%
-
Price per share
-
$1.62
-
Number of holders
-
94
-
Value change
-
-$2,972,560
-
Number of buys
-
37
-
Number of sells
-
42
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q4 2022
As of 31 Dec 2022,
Kronos Bio, Inc. - Common Stock (KRON) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,494,303 shares.
The largest 10 holders included
Omega Fund Management, LLC, BlackRock Inc., Vida Ventures Advisors, LLC, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, Artal Group S.A., VANGUARD GROUP INC, Nextech Invest Ltd., Wildcat Capital Management, LLC, and Alphabet Inc..
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.